Acefylline piperazine

This classification denotes a bronchodilator with the molecular formula 2C9H10N4O4.C4H10N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 12I91IOS6Z chemically known as 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)acetic acid;piperazine but generally known as acefylline, which bears US NIH Compound Identifier 87819. European Medicines Agency schedules Acefylline piperazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12706MIG. The term ACEFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, no. 5 1981, list 21). Most nations schedule acefylline piperazine under HS 29395900 and SITC 54145. As of Q4 2014, ACEFYLLINE PIPERAZINE remains the US FDA Preferred Term for this commodity. Acefylline piperazine bears US NLM identifiers UMLS ID C0771707 and NCI Concept Code C74218. SMILES: CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)O.CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(=O)O.C1CNCCN1.